Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer

被引:0
作者
Unurjargal Bayasgalan
Sung Ho Moon
Jong Hwi Jeong
Tae Hyun Kim
Kwan Ho Cho
Yang-Gun Suh
机构
[1] National Cancer Center,Proton Therapy Center, Research Institute and Hospital
[2] National Cancer Center,Department of Radiation Oncology
来源
Radiation Oncology | / 16卷
关键词
Non-small cell lung cancer; Stage I; Proton beam therapy; Stereotactic ablative radiotherapy; Hypofractionated radiation therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 148 条
[1]  
Aberle DR(2011)Reduced lung-cancer mortality with low-dose computed tomographic screening New Engl J Med 365 395-409
[2]  
Adams AM(2014)Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial J Thorac Cardiovasc Surg 147 747-752
[3]  
Berg CD(2013)Surgical management of lung cancer Semin Intervent Radiol 30 133-140
[4]  
Black WC(2015)Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials Lancet Oncol 16 630-637
[5]  
Clapp JD(2017)Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline Pract Radiat Oncol 7 295-301
[6]  
Su S(2010)Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 1070-1076
[7]  
Scott WJ(2015)Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry J Radiat Oncol 4 55-63
[8]  
Allen MS(2018)Stereotactic body radiation therapy for operable early-stage lung cancer: findings from the NRG oncology RTOG 0618 trial JAMA Oncol 4 1263-1266
[9]  
Darling GE(2019)Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial Lancet Oncol 20 494-503
[10]  
Decker PA(2006)Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 4833-4839